pocketful logo
Procter & Gamble Health Ltd logo

Procter & Gamble Health Ltd

NSE: PGHL BSE: 500126

5305

(0.04)%

Sun, 01 Feb 2026, 09:01 pm

procter & gamble health limite News

P&G Health Board to Consider Interim Dividend on Feb 6

Procter & Gamble Health Limited has revised its board meeting agenda for February 6, 2026, to include consideration of interim dividend declaration for FY26, in addition to previously scheduled matters.

21 Jan 2026

co actions results

Procter & Gamble Health Limited Appoints Shashank Srowthy as Executive Director

Procter & Gamble Health Limited confirmed the appointment of Shashank Srowthy as Executive Director for five years effective October 1, 2025, following shareholder approval through postal ballot on November 16, 2025. Srowthy brings 14 years of finance experience across PG operations in India, Dubai and Singapore, and holds no shares in the company nor any relationship with existing directors.

18 Nov 2025

corporate action

Procter & Gamble Health Limited Reports Quarterly Financial Results

Procter & Gamble Health Limited announced its unaudited financial results for the quarter ended September 30, 2025. The company reported revenue from operations of ₹54.5 crores for the quarter, compared to ₹54.7 crores in the previous quarter and ₹51.1 crores in the corresponding quarter of the previous year. Net profit for the quarter stood at ₹88.6 crores, significantly higher than ₹66.2 crores in the previous quarter and ₹82.5 crores in the same quarter last year. For the six-month period ended September 30, 2025, revenue was ₹109.3 crores with net profit of ₹154.8 crores. The company's earnings per share for the quarter was ₹53.34. Cash and cash equivalents increased to ₹279.3 crores as of September 30, 2025, from ₹182.3 crores as of March 31, 2025. The Board of Directors approved these results at a meeting held on November 5, 2025.

05 Nov 2025

earnings

Procter & Gamble Health Reports Higher Q2 Profit and Revenue Growth

Procter & Gamble Health reported Q2 net profit of 885.4 million rupees compared to 823.3 million rupees in the same period last year. Revenue increased to 3.25 billion rupees from 3.13 billion rupees year-over-year. EBITDA rose to 1.2 billion rupees from 1.14 billion rupees, while EBITDA margin improved to 37.02% from 36.39% in the previous year.

05 Nov 2025

earnings

Procter & Gamble Health Limited Completes Director Appointment Process for Shashank Srowthy

Procter & Gamble Health Limited announced that Mr. Shashank Srowthy has been allotted Director Identification Number (DIN) 11317956 by the Ministry of Corporate Affairs. Srowthy was appointed as Additional Director (Executive) effective October 1, 2025. The DIN was allotted through an order dated September 26, 2025, completing the appointment process that was initially announced on September 16, 2025.

01 Oct 2025

corporate governance

Showing 15 of 26
Rows per page:

Market Current News

Medplus Health Services Limite logo

Medplus Health Services Limite

MedPlus Subsidiary Faces Drug License Suspension

MedPlus Health Services subsidiary Optival Health Solutions receives 25-day drug license suspension for Maharashtra store, potentially impacting revenue by Rs 7.53 lacs under regulatory violation.

31 Jan 2026

stocks

Allied Blenders and Distillers logo

Allied Blenders and Distillers

Allied Blenders Gets Partial Relief in Tax Appeals

Allied Blenders and Distillers receives partial relief from Commissioner of Income Tax (Appeals) in pending appeals for assessment years 2014-15 to 2024-25, with orders dated January 30, 2026.

31 Jan 2026

stocks

GRAMEVA LIMITED logo

GRAMEVA LIMITED

Grameva Limited Open Offer by Maneesha Singh Group

Mrs. Maneesha Singh and associates announce open offer to acquire 26.00% equity shares of Grameva Limited at Rs. 30/- per share under SEBI SAST Regulations following share purchase agreement.

31 Jan 2026

co actions results

International Gemmological Ins logo

International Gemmological Ins

IGI India Board Approves USD 18 Million Investment Plan

International Gemmological Institute (India) Limited's board approved USD 9 million investment in IGI Belgium, which will further invest USD 9 million in IGI USA for strategic expansion.

31 Jan 2026

co actions results

GABRIEL INDIA LTD. logo

GABRIEL INDIA LTD.

Gabriel India CPO Prashant Shah Retires Jan 31

Gabriel India Limited announces retirement of Chief Purchase Officer Mr. Prashant Shah effective January 31, 2026, as disclosed under SEBI Regulation 30 compliance requirements.

31 Jan 2026

stocks

Showing 15 of 79726
Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800